<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HC4D95B8311D944B4B2F154A84F547596" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 5774 IH: Combating Opioid Abuse for Care in Hospitals Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-05-11</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 5774</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180511">May 11, 2018</action-date><action-desc><sponsor name-id="C001107">Mr. Curbelo of Florida</sponsor> (for himself, <cosponsor name-id="K000382">Ms. Kuster of New Hampshire</cosponsor>, <cosponsor name-id="D000617">Ms. DelBene</cosponsor>, and <cosponsor name-id="B001305">Mr. Budd</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name>, and in addition to the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require the Secretary of Health and Human Services to develop guidance on pain management and
			 opioid use disorder prevention for hospitals receiving payment under part
			 A of the Medicare program, provide for opioid quality measures
			 development, and provide for a technical expert panel on reducing surgical
			 setting opioid use and data collection on perioperative opioid use, and
			 for other purposes.</official-title></form>
	<legis-body id="H9CFDD3CC4A1A4542A22898690B83CC7D" style="OLC">
 <section id="H1CD9BBD5AAE9496EA99482DD75B0F7C5" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Combating Opioid Abuse for Care in Hospitals Act of 2018</short-title></quote> or the <quote><short-title>COACH Act of 2018</short-title></quote>.</text> </section><section id="HCF835C1D62E3415197A96D1DF8C4F55B" section-type="subsequent-section"><enum>2.</enum><header>Developing guidance on pain management and opioid use disorder prevention for hospitals receiving payment under part A of the Medicare program</header> <subsection id="HC0821E8C05D94623AAF72D1A1D9C3BAF"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than January 1, 2019, the Secretary of Health and Human Services (in this section referred to as the <quote>Secretary</quote>) shall develop and publish on the public website of the Centers for Medicare &amp; Medicaid Services guidance for hospitals receiving payment under part A of title XVIII of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395c">42 U.S.C. 1395c</external-xref> et seq.) on pain management strategies and opioid use disorder prevention strategies with respect to individuals entitled to benefits under such part.</text>
 </subsection><subsection id="H02C69DAE6D344EE89ECCA5BC3698A142"><enum>(b)</enum><header>Consultation</header><text>In developing the guidance described in subsection (a), the Secretary shall consult with relevant stakeholders, including—</text>
 <paragraph id="HC2CFEC23FBBF47808851A0786DD4A7E4"><enum>(1)</enum><text>medical professional organizations;</text> </paragraph><paragraph id="H1213B8DF2C0445D18C0D022983C0FF10"><enum>(2)</enum><text>providers and suppliers of services (as such terms are defined in section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>));</text>
 </paragraph><paragraph id="H2F75E473F9BC4FD3AD8D50F9F14D851E"><enum>(3)</enum><text display-inline="yes-display-inline">health care consumers or groups representing such consumers; and</text> </paragraph><paragraph id="H227666D4E5CA4BFB8F91E98FA0AF6F89"><enum>(4)</enum><text>other entities determined appropriate by the Secretary.</text>
 </paragraph></subsection><subsection id="HFB5EDA2D3A80432BBF2735A279F251BE"><enum>(c)</enum><header>Contents</header><text>The guidance described in subsection (a) shall include, with respect to hospitals and individuals described in such subsection, the following:</text>
 <paragraph id="H8FB132DD493846A099338707F2A9DFCB"><enum>(1)</enum><text>Best practices regarding evidence-based screening and practitioner education initiatives relating to screening and treatment protocols for opioid use disorder, including—</text>
 <subparagraph id="H6C6B6D3FCABB423E9210E6975ECF0F43"><enum>(A)</enum><text>methods to identify such individuals at-risk of opioid use disorder, including risk stratification;</text> </subparagraph><subparagraph id="HB251082FA049463F8368E7D0B81F5A94"><enum>(B)</enum><text>ways to prevent, recognize, and treat opioid overdoses; and</text>
 </subparagraph><subparagraph id="H6FA737CE3AF944D984E0BEB4E3BD7853"><enum>(C)</enum><text>resources available to such individuals, such as opioid treatment programs, peer support groups, and other recovery programs.</text>
 </subparagraph></paragraph><paragraph id="H276918590F4543D695D5BF70D0367439"><enum>(2)</enum><text>Best practices for such hospitals to educate practitioners furnishing items and services at such hospital with respect to pain management and substance use disorders, including education on—</text>
 <subparagraph id="H06AA31E9D1D84E70A12A6B1BD587D6CC"><enum>(A)</enum><text>the adverse effects of prolonged opioid use;</text> </subparagraph><subparagraph id="H6393CAB491D7471594BA1653A20C5D9F"><enum>(B)</enum><text>non-opioid, evidence-based, non-pharmacological pain management treatments;</text>
 </subparagraph><subparagraph id="H0ABF429F6A6542BC888D23641849624E"><enum>(C)</enum><text>monitoring programs for individuals who have been prescribed opioids; and</text> </subparagraph><subparagraph id="H74E81F4165F045E7AA55232AA6DB1CE9"><enum>(D)</enum><text>the prescribing of naloxone along with an initial opioid prescription.</text>
 </subparagraph></paragraph><paragraph id="H6F90D4C183A84B728D371247F8F031B7"><enum>(3)</enum><text>Best practices for such hospitals to make such individuals aware of the risks associated with opioid use (which may include use of the notification template described in paragraph (4)).</text>
 </paragraph><paragraph id="H62544E44BE5842B48C816F41096D1E82"><enum>(4)</enum><text>A notification template developed by the Secretary, for use as appropriate, for such individuals who are prescribed an opioid that—</text>
 <subparagraph id="H6D02C96871A540298B15A46647CD7EDA"><enum>(A)</enum><text>explains the risks and side effects associated with opioid use (including the risks of addiction and overdose) and the importance of adhering to the prescribed treatment regimen, avoiding medications that may have an adverse interaction with such opioid, and storing such opioid safely and securely;</text>
 </subparagraph><subparagraph id="HFA4F91A90FAA425CA0105921AA3793B2"><enum>(B)</enum><text>highlights multimodal and evidence-based non-opioid alternatives for pain management;</text> </subparagraph><subparagraph id="H971540655DBE4D7F8F8F38ACE2CB612D"><enum>(C)</enum><text>encourages such individuals to talk to their health care providers about such alternatives;</text>
 </subparagraph><subparagraph id="H7F34F67888AE4F8CA21D6E191B26EBD3"><enum>(D)</enum><text>provides for a method (through signature or otherwise) for such an individual, or person acting on such individual’s behalf, to acknowledge receipt of such notification template;</text>
 </subparagraph><subparagraph id="H91FF2D0C9AEC46799AB8B61D47F25F8A"><enum>(E)</enum><text>is worded in an easily understandable manner and made available in multiple languages determined appropriate by the Secretary; and</text>
 </subparagraph><subparagraph id="HE7B7CD28100A4F9EB8D3A2869D34ACE2"><enum>(F)</enum><text>includes any other information determined appropriate by the Secretary.</text> </subparagraph></paragraph><paragraph id="H610C2860011D409988DE4CF344A157C1"><enum>(5)</enum><text>Best practices for such hospital to track opioid prescribing trends by practitioners furnishing items and services at such hospital, including—</text>
 <subparagraph id="H28990CE46E0D4C448121BADADEDE7A00"><enum>(A)</enum><text>ways for such hospital to establish target levels, taking into account the specialties of such practitioners and the geographic area in which such hospital is located, with respect to opioids prescribed by such practitioners;</text>
 </subparagraph><subparagraph id="H7E55D3EA0760425DABF53BAA418C2BB5"><enum>(B)</enum><text>guidance on checking the medical records of such individuals against information included in prescription drug monitoring programs;</text>
 </subparagraph><subparagraph id="H1C061D5C5BA74027AAED37A7458890B4"><enum>(C)</enum><text>strategies to reduce long-term opioid prescriptions; and</text> </subparagraph><subparagraph id="H2D48457FB7964942B3AC6DBBEF0E6B5F"><enum>(D)</enum><text>methods to identify such practitioners who may be over-prescribing opioids.</text>
 </subparagraph></paragraph><paragraph id="H0D7B726ED0244E2DB5E0C626A2786C40"><enum>(6)</enum><text>Other information the Secretary determines appropriate, including any such information from the Opioid Safety Initiative established by the Department of Veterans Affairs or the Opioid Overdose Prevention Toolkit published by the Substance Abuse and Mental Health Services Administration.</text>
				</paragraph></subsection></section><section display-inline="no-display-inline" id="H2D25237E4A4040DBB0ADF717C00C101B"><enum>3.</enum><header>Requiring the review of quality measures relating to opioids and opioid use disorder treatments
			 furnished under the medicare program and other federal health care
			 programs</header>
 <subsection id="H657C05047CCB41D0B80DABF5F5C524A0"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1890A of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395aaa-1">42 U.S.C. 1395aaa–1</external-xref>) is amended by adding at the end the following new subsection:</text>
				<quoted-block id="H289525A54CF4452285608926B3BCCA08" style="OLC">
					<subsection id="H7D1090FC35B04A3AAF34BD9272737571"><enum>(g)</enum><header>Technical expert panel review of opioid and opioid use disorder quality measures</header>
 <paragraph id="HBB03D36083874A9A8A74828649E1A1E5"><enum>(1)</enum><header>In general</header><text>Not later than 180 days after the date of the enactment of this subsection, the Secretary shall establish a technical expert panel for purposes of reviewing quality measures relating to opioids and opioid use disorders, including care, prevention, diagnosis, health outcomes, and treatment furnished to individuals with opioid use disorders. The Secretary may elect to establish such panel through a contract with the consensus-based entity with a contract in effect under section 1890.</text>
 </paragraph><paragraph id="HBBF63B021A3E4C9D84E6416857CB61C5"><enum>(2)</enum><header>Review and assessment</header><text>Not later than 1 year after the date the technical expert panel described in paragraph (1) is established (and periodically thereafter as the Secretary determines appropriate), the technical expert panel shall—</text>
 <subparagraph id="H44E81144F67543819EA7036F1799FC52"><enum>(A)</enum><text>review quality measures that relate to opioids and opioid use disorders, including existing measures and those under development;</text>
 </subparagraph><subparagraph id="H19C809D07BE94DD1A624EFF28478E0A8"><enum>(B)</enum><text>identify gaps in areas of quality measurement that relate to opioids and opioid use disorders, and identify measure development priorities for such measure gaps; and</text>
 </subparagraph><subparagraph id="H842BADF2BBD9405692D0186A5D9D91BA"><enum>(C)</enum><text>make recommendations to the Secretary on quality measures with respect to opioids and opioid use disorders for purposes of improving care, prevention, diagnosis, health outcomes, and treatment, including recommendations for revisions of such measures, need for development of new measures, and recommendations for including such measures in quality reporting programs, value-based purchasing programs, accountable care organizations, and alternative payment models under this title.</text>
 </subparagraph></paragraph><paragraph id="H75C59D3A54A04489875A77D4A4D0DB2E"><enum>(3)</enum><header>Consideration of measures by secretary</header><text>The Secretary shall consider—</text> <subparagraph id="HACE5C2C054F44209B95CC6B835CBC9EE"><enum>(A)</enum><text>using opioid and opioid use disorder measures (including measures used under the Merit-Based Incentive Payment System under section 1848(q), measures recommended under paragraph (2)(C), and other such measures identified by the Secretary) in Alternative Payment Models under section 1833(z)(3)(C) and in the Shared Savings Program under section 1899; and</text>
 </subparagraph><subparagraph id="HBBA7B0EA20624ADBB340B09D0DBD40F9"><enum>(B)</enum><text>using opioid measures described in subparagraph (A), as applicable, in the Hospital Inpatient Quality Reporting program under section 1886(b)(3)(B)(viii), in the hospital value-based purchasing program under section 1886(o), and under other value-based purchasing programs under this title.</text>
 </subparagraph></paragraph><paragraph id="H27AB25D4749A43999A980AA6C0F80D34"><enum>(4)</enum><header>Prioritization of measure development</header><text>The Secretary shall prioritize for measure development the gaps in quality measures identified under paragraph (2)(C).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
 </subsection><subsection id="HE35ECD4F80A04FAD881407829BA20763"><enum>(b)</enum><header>Expedited endorsement process for opioid measures</header><text display-inline="yes-display-inline">Section 1890(b)(2) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395aaa">42 U.S.C. 1395aaa(b)(2)</external-xref>) is amended by adding at the end the following new flush sentence:</text>
				<quoted-block display-inline="no-display-inline" id="H82AD2A927129403FB58A1565C5EFFCB9" style="OLC">
					<quoted-block-continuation-text quoted-block-continuation-text-level="paragraph">Such endorsement process shall, as determined practicable by the entity, provide for an expedited
			 process with respect to the endorsement of measures relating to opioids
			 and opioid use disorders.</quoted-block-continuation-text><after-quoted-block>.</after-quoted-block></quoted-block>
			</subsection></section><section id="HF6DAB835B1524C5A859FBE335109E7F7" section-type="subsequent-section"><enum>4.</enum><header>Technical expert panel on reducing surgical setting opioid use; Data collection on perioperative
			 opioid use</header>
			<subsection id="HEA3615CEADA14C199C4C6A9BC37C6D11"><enum>(a)</enum><header>Technical expert panel on reducing surgical setting opioid use</header>
 <paragraph id="H068349A6AA5A4095BE31850E30363F9A"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 6 months after the date of the enactment of this Act, the Secretary of Health and Human Services shall convene a technical expert panel, including medical and surgical specialty societies and hospital organizations, to provide recommendations on reducing opioid use in the inpatient and outpatient surgical settings and on best practices for pain management, including with respect to the following:</text>
 <subparagraph id="HF2D17AC2CBC645A1A1017F232C0D0767"><enum>(A)</enum><text display-inline="yes-display-inline">Approaches that limit patient exposure to opioids during the perioperative period, including pre-surgical and post-surgical injections, and that identify such patients at risk of opioid use disorder pre-operation.</text>
 </subparagraph><subparagraph id="HEA15F1104354484CAFEC1D35C3614E0E"><enum>(B)</enum><text>Shared decision making with patients and families on pain management, including recommendations for the development of an evaluation and management code for purposes of payment under the Medicare program under title XVIII of the Social Security Act that would account for time spent on shared decision making.</text>
 </subparagraph><subparagraph id="HDD57728C00064A6EAC90B54994100E87"><enum>(C)</enum><text>Education on the safe use, storage, and disposal of opioids.</text> </subparagraph><subparagraph id="H760A4ABD306B4E29B0E7F12FC945CF34"><enum>(D)</enum><text>Prevention of opioid misuse and abuse after discharge.</text>
 </subparagraph><subparagraph id="HDFDD62486BAD4104B4313C81BAFD431D"><enum>(E)</enum><text>Development of a clinical algorithm to identify and treat at-risk, opioids-tolerant patients and reduce reliance on opiates for acute pain during the perioperative period.</text>
 </subparagraph></paragraph><paragraph id="H77C055F3A03B4AAFAA505CDC3F45452D"><enum>(2)</enum><header>Report</header><text>Not later than 1 year after the date of the enactment of this Act, the Secretary shall submit to Congress and make public a report containing the recommendations developed under paragraph (1) and recommendations for broader implementation of pain management protocols that limit the use of opioids in the perioperative setting and upon discharge from such setting.</text>
 </paragraph></subsection><subsection id="HE49CB5B1326A40808289A955B9A457BE"><enum>(b)</enum><header>Data collection on perioperative opioid use</header><text>Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report that contains the following:</text>
 <paragraph id="H1FFC02B4F7E649E191B938ABC95A518A"><enum>(1)</enum><text>The diagnosis-related group codes identified by the Secretary as having the highest volume of surgeries.</text>
 </paragraph><paragraph id="HC20B1F1ED8B047DCBF1226366A5DF619"><enum>(2)</enum><text>With respect to each of such diagnosis-related group codes so identified, a determination by the Secretary of the data that is both available and reported on opioid use following such surgeries, such as with respect to—</text>
 <subparagraph id="HF67999D4676D4BA2B50B59DB497D1CBA"><enum>(A)</enum><text display-inline="yes-display-inline">surgical volumes, practices, and opioid prescribing patterns;</text> </subparagraph><subparagraph id="H6A1DAAA8E5654B8C8205BF0034716BDC"><enum>(B)</enum><text>opioid consumption, including—</text>
 <clause id="H016EFDFBF99742A69AEECF5F9B2AC62B"><enum>(i)</enum><text>perioperative days of therapy;</text> </clause><clause id="H6394C38BCA5A485EA32F2F79BCB1FFEC"><enum>(ii)</enum><text>average daily dose at the hospital, including dosage greater than 90 milligram morphine equivalent;</text>
 </clause><clause id="HAD807FAAAD0549C8A5E7197C91C614BB"><enum>(iii)</enum><text>post-discharge prescriptions and other combination drugs that are used before intervention and after intervention;</text>
 </clause><clause id="H00A1C478A0AB4608A7E99AD256EF3CB3"><enum>(iv)</enum><text>quantity and duration of opioid prescription at discharge; and</text> </clause><clause id="H21949571DAF14B8AB10F5E73CEA3BC97"><enum>(v)</enum><text>quantity consumed and number of refills;</text>
 </clause></subparagraph><subparagraph id="H1FF011E146E5410EAC2CCB59665D372A"><enum>(C)</enum><text>regional anesthesia and analgesia practices, including pre-surgical and post-surgical injections;</text> </subparagraph><subparagraph id="H7BE3BEEF75124372A39C1FC62D2ADA60"><enum>(D)</enum><text>naloxone reversal;</text>
 </subparagraph><subparagraph id="HFEBF65BB9DF24E2599EE165B8D3EC88B"><enum>(E)</enum><text>post-operative respiratory failure;</text> </subparagraph><subparagraph id="HA6DA3BA5BC134E6DA8350A5944737B13"><enum>(F)</enum><text>information about storage and disposal; and</text>
 </subparagraph><subparagraph id="H4A5F2B6740F540CB8791E5E3C58C4BCD"><enum>(G)</enum><text>such other information as the Secretary may specify.</text> </subparagraph></paragraph><paragraph id="HD7B7C6B36A2B4CC2B65854460CA0A39E"><enum>(3)</enum><text display-inline="yes-display-inline">Recommendations for improving data collection on perioperative opioid use, including an analysis to identify barriers to collecting, reporting, and analyzing the data described in paragraph (2), including barriers related to technological availability.</text>
				</paragraph></subsection></section><section id="H59FF8A8FC73D430DA9C58AA49FA8A966"><enum>5.</enum><header>Requiring the posting and periodic update of opioid prescribing guidance for Medicare beneficiaries</header>
 <subsection id="HDB9A4598E00D4FBBAABD3350E74ADE9E"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the <quote>Secretary</quote>) shall post on the public website of the Centers for Medicare &amp; Medicaid Services all guidance published by the Department of Health and Human Services on or after January 1, 2016, relating to the prescribing of opioids and applicable to opioid prescriptions for individuals entitled to benefits under part A of title XVIII of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395c">42 U.S.C. 1395c</external-xref> et seq.) or enrolled under part B of such title of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395j">42 U.S.C. 1395j</external-xref> et seq.).</text>
			</subsection><subsection id="H3DFF8D50EAF147E9B21EB9FAA976C082"><enum>(b)</enum><header>Update of guidance</header>
 <paragraph id="H45D6708419314EB189DB103DEDFBD70D"><enum>(1)</enum><header>Periodic update</header><text display-inline="yes-display-inline">The Secretary shall, in consultation with the entities specified in paragraph (2), periodically (as determined appropriate by the Secretary) update guidance described in subsection (a) and revise the posting of such guidance on the website described in such subsection.</text>
 </paragraph><paragraph id="HD35F177483954705A6E4FBB380CF9284"><enum>(2)</enum><header>Consultation</header><text>The entities specified in this paragraph are the following:</text> <subparagraph id="H30BFE32DAD3D4F1B86BD80C2874C42AF"><enum>(A)</enum><text display-inline="yes-display-inline">Medical professional organizations.</text>
 </subparagraph><subparagraph id="H49014110CBCC4EB09BA5AC45F2798AF3"><enum>(B)</enum><text>Providers and suppliers of services (as such terms are defined in section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>)).</text>
 </subparagraph><subparagraph id="HFB9C0CA77608415E892102624412529B"><enum>(C)</enum><text>Health care consumers or groups representing such consumers.</text> </subparagraph><subparagraph id="HB3D670EF12C04C0FA8A47B16535A965E"><enum>(D)</enum><text>Other entities determined appropriate by the Secretary.</text>
					</subparagraph></paragraph></subsection></section></legis-body></bill>


